OCT 06, 2016 12:00 PM PDT

The Clinical and Economic Impact of Precision Cancer Medicine

Speaker
  • Executive Director of Precision Medicine & Precision Genomics, Intermountain Healthcare
    Biography
      Dr. Lincoln Nadauld, MD, PhD, is the Executive Director of Precision Medicine and Precision Genomics at Intermountain Healthcare, an integrated healthcare system located in the Intermountain West. Dr. Nadauld completed clinical training in Medical Oncology at Stanford University School of Medicine, where he is still part of the research faculty focusing on cancer genomics and personalized cancer medicine. Dr. Nadauld oversees the clinical implementation of genomics cancer medicine across Intermountain Healthcare's 22 hospitals and 180 physician clinics. In his spare time Dr. Nadauld enjoys attending his children's sporting events, water sports, fishing and athletics.

    Abstract

    Precision medicine is a rapidly evolving paradigm powered by emerging technological, diagnostic, and pharmacological capabilities.  The clinical application of precision medicine holds promise across medical disciplines, and has become increasingly prominent in advanced cancer patients where genomic analyses can readily identify actionable somatic variants.  In spite of the clinical potential of precision cancer medicine, widespread implementation has been limited, largely due to the paucity of robust clinical experience in the space.  Leveraging the unique aspects of a large, integrated health delivery network, we have clinically implemented a comprehensive precision medicine program for advanced cancer patients.  We outline the Precision Cancer Genomics Program at Intermountain Healthcare, and provide insights into the successes, challenges and economic impact associated with the de novo implementation of an enterprise-wide precision medicine program.
     


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    MAR 11, 2020 6:00 AM PDT
    C.E. CREDITS
    MAR 11, 2020 6:00 AM PDT
    The locomotion of humans and other animals requires a seamless flow of information from sensory modalities all the way to the motor periphery. As such, locomotion is an excellent system for...
    Loading Comments...
    Show Resources